Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Karla S. Garcia-Salazar has a total of 25 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    From Agro-Industrial Waste to Food Safety: Sustainable Biochars Derived from Orange Peel and Guava Leaves for the Removal of Aflatoxin B1 in Poultry Feed Using an In Vitro Model

    by Karla S. García-Salazar, Raquel López-Arellano, Juan D. Latorre, Elvia Adriana Morales Hipólito, Jorge L. Mejía-Méndez, Edgar R. López-Mena, Alma Victoria Sánchez-Mendoza, Alma Vázquez-Durán, Guillermo Tellez-Isaias, Abraham Méndez-Albores, et al.

    Aflatoxin B1 (AFB1) contamination of feed used in poultry farming is an important issue in food safety since it compromises animal productivity and leads to the transfer of toxic waste to the food chain. In this sense, as an alternative to conventional mineral adsorbents, in the present study, two sustainable and low-cost biochars were obtained from agro-industrial waste of orange peel (B-OP) and guava leaves (B-GL) to evaluate their efficiency in the removal of AFB1 in an in vitro avian model. Biochars were obtained from pyrolysis and characterized in terms of particle size, surface area, morphology, surface charge, surface chemistry, and pore size. Furthermore, their adsorption capacity was evaluated in an avian in vitro model. The results showed that B-OP had a smaller particle size (55.30 µm), a larger specific surface area (31.50 m2/g), and a smaller pore size (2.38 nm) than B-GL (82.88 µm, 9.74 m2/g, and 6.24 nm). Furthermore, the biochars presented different morphologies, FTIR spectra, and zeta potentials. In the avian in vitro model, the feed matrix reduced the effectiveness of AFB1 removal compared to the in vitro model using only buffer solutions. However, B-OP (27.4%) significantly outperformed B-GL (22.7%) in the intestinal segment. The valorization of these agro-industrial wastes into biochar represents an economical and sustainable strategy for removing AFB1 and strengthening food security.

  • Open Access

    From metal mass to nanoparticle flux: a bimetallic strategy for controlling Enterococcus cecorum in poultry systems *

    by Diego Samuel Ortiz-Baz, Juan de Dios Figueroa-Cárdenas, Karla S García-Salazar, Daniel Hernández-Patlán, Guillermo Téllez-Isaías, Alma Vázquez-Durán, Erika Méndez, Abraham Méndez-Albores

    Enterococcus cecorum is an emerging opportunistic pathogen in poultry and its increasing antimicrobial resistance highlights the need for alternative control strategies. In this study, monometallic silver (AgNPs), copper (CuNPs), and bimetallic silver–copper (AgCuNPs) nanoparticles were synthesized and evaluated for their antibacterial activity against a clinical E. cecorum isolate. Physicochemical characterization by UV–Vis spectroscopy, zeta potential, transmission electron microscopy (TEM), X-ray diffraction, and nanoparticle tracking analysis (NTA) confirmed the formation of NPs with distinct size, surface, and dispersion properties. TEM revealed mean particle sizes of 10.5 ± 4.1 nm (AgNPs), 22.0 ± 9.3 nm (CuNPs), and 6.7 ± 3.4 nm (AgCuNPs), while all systems exhibited negative surface charge. Antimicrobial activity was concentration dependent, AgNPs exhibited strong efficacy, with a minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of 6 and 36 ppm, respectively, whereas CuNPs showed reduced bactericidal activity (MIC/MBC: 6/> 48 ppm). In contrast, AgCuNPs achieved a lower MIC (3 ppm) while maintaining a comparable MBC (48 ppm), indicating enhanced antibacterial potency on a mass-concentration basis. Moreover, NTA revealed that, despite requiring lower total metal mass, AgCuNPs delivered a greater nanoparticle flux at the MIC (3.8 × 10 9 NPs ml −1 ) than monometallic NPs (∼2.3 × 10 9 NPs ml −1 ), representing an approximately 1.7-fold increase in particle concentration. Similarly, the nanoparticle-to-bacteria ratio was also higher for AgCuNPs (37 800 NPs CFU −1 ) compared with monometallic NPs (23 000 NPs CFU −1 ), indicating increased nanoparticle availability per bacterial cell during antimicrobial exposure. This increased particle availability, together with reduced particle and crystallite size, likely enhanced nanoparticle–cell interactions and contributed to improved antibacterial activity. Taken together, these findings support AgCuNPs as promising alternative or complementary antimicrobial agents for controlling E. cecorum in poultry production systems and demonstrate the value of nanoparticle flux and the nanoparticle-to-bacteria ratio as complementary descriptors for interpreting nano–bio antimicrobial performance beyond mass-based concentration metrics.

  • Open Access

    Biochar Derived from Agro-Industrial Coconut Shell Waste for the Removal of Aflatoxin B1 Using an In Vitro Model That Considers Buffer Solutions and an In Vitro Avian Digestion Model

    by Karla S. García-Salazar, Raquel López-Arellano, Jesús A. Maguey-Gonzalez, Juan D. Latorre, Elvia Adriana Morales Hipólito, Maykel González-Torres, Jorge L. Mejía-Méndez, Alma Vázquez-Durán, Guillermo Tellez-Isaias, Abraham Méndez-Albores, et al.

    The use of agro-industrial waste to obtain biochar has emerged as an environmentally friendly, low-cost, effective, profitable, and sustainable strategy for the removal of aflatoxin B1 (AFB1), a highly toxic and carcinogenic mycotoxin of importance in poultry production systems because it can cause serious economic losses, affect hatchability, egg production, and the growth of birds, and can cause their death. In this sense, the objective of the present study was to obtain a sustainable and low-cost biochar derived from agro-industrial coconut shell waste (BCS) and evaluate its AFB1 adsorption capacity using a conventional method based on buffer solutions and an in vitro avian digestion model that simulates the conditions of the gastrointestinal tract of the broiler chicken. The results showed that the adsorption capacity of BCS on AFB1 (250 ng/mL) at both pH 5.0 and 1.2 was close to 100%, while at pH 6.8, the adsorption of AFB1 was 86.24%. However, in the in vitro avian digestibility model, the adsorption capacity of BSC on AFB1 was 32.96%, thus highlighting the importance of considering factors that can affect the adsorption capacity of materials before in vivo studies, as this can lead to overestimations of results and, therefore, ineffective treatments or unexpected results in animals.


  • Open Access

    Surface-engineered fluorinated silica nanoparticles for removal of the potent hepatocarcinogen aflatoxin B1 in a dynamic gastrointestinal model

    by Alfredo Nava-Villeda, Alan Enriquez-Tavera, Diego Samuel Ortiz-Baz, Juan José Sánchez-Romero, Karla S. García-Salazar, Daniel Hernández-Patlán, Alfredo Maciel-Cerda, Maykel González-Torres, Alma Vázquez-Durán, Abraham Méndez-Albores


  • Nanomedicine: A Dual Approach to Diagnosis and Therapy

    by Bruno Solis-Cruz, Karla S. Garcia-Salazar, Raquel López-Arellano, Angélica L. Sánchez-López, Jorge L. Mejía-Méndez, Daniel Hernandez-Patlan

  • Open Access

    Nanotechnological Innovations in the Treatment and Diagnosis of Viral Pathogens: Biomedical and Macromolecular Insights

    by Marco Chávez-Tinoco, Bruno Solis-Cruz, Edgar R. López-Mena, Karla S. García-Salazar, Daniel Hernández-Patlán, Jorge L. Mejía-Méndez

    Viral diseases remain a persistent threat to global health, agriculture, and biodiversity, as demonstrated by recent pandemics. The high mutation rates, diversity, and intricate replication mechanisms within a host can often challenge conventional detection and therapeutic approaches. The emergence of novel viruses underscores the critical importance of innovative and multidisciplinary strategies to outpace these diseases. In this context, nanotechnology has emerged as a transformative frontier, offering unique tools to address the limitations of traditional virology. This review examines the latest nanotechnological innovations designed to combat viral diseases. Like the development of advanced nanoplatforms, metallic and polymeric nanostructures, and carbon-based materials, and evaluating their roles in viral theranostics. This article provides critical biomedical insights into the function and relationship of nanomaterials, mechanisms of action, and their interaction with biological systems. This work aims to provide a valuable resource for guiding future research toward the clinical translation of nanomaterial-based strategies for the prevention, diagnosis, and treatment of viral infections.


  • Open Access

    Design of Geraniol-Loaded Nanocapsules for Use Against Salmonella Infantis: Evaluation in an In Vitro Poultry Model

    by Karla S. Garcia-Salazar, Hector J. Leon-Solano, Jesus A. Maguey-Gonzalez, Juan D. Latorre, Raquel López-Arellano, Elvia A. Morales Hipólito, Roberto Díaz-Torres, Miguel Morales Rodríguez, Alma Vázquez-Durán, Guillermo Tellez-Isaias, et al.

    Background/Objectives: Salmonella Infantis (S. Infantis) is a bacterium that has gained importance in public health over the last decade due to its high pathogenicity and resistance to antibiotics. Therefore, the objective of the present study was to present key considerations for the design and development of geraniol-loaded nanocapsules for its delivery in the drinking water or feed of broiler chickens and to evaluate its potential as an antimicrobial agent against S. Infantis using a standard in vitro microplate assay and a model that simulates the pH and feed conditions of the crop of broiler chickens. Methods: Using a 3k factorial experimental design, geraniol nanocapsule-based formulations were selected, and their antimicrobial activity was evaluated in in vitro models. Results: The results demonstrated that geraniol alone exhibits antimicrobial action against S. Infantis mainly due to its lipophilicity, hydrophobicity and the presence of the hydroxyl group found in its chemical structure, but when formulated in nanocapsular systems, the interaction of its components tends to reduce its antimicrobial action, especially the mixture of Tween 80:Span 80 and Miglyol® 810N. Furthermore, the use of the in vitro model that simulates the crop of broiler chickens demonstrated that the formulation also has interactions with the feed components, completely nullifying the antimicrobial action of geraniol compared to that obtained in the in vitro microplate model. Conclusions: Preformulation studies during the development of nanocapsule-based formulations should be considered for the correct selection of the components of a formulation to ensure its effectiveness, without only considering the physicochemical and stability properties of these as is frequently seen in studies.